Dr. Hamill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19 Village Sq
Chelmsford, MA 01824Phone+1 978-256-5600Fax+1 978-703-0250
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 2012 - 2014
- Yale-New Haven Medical CenterResidency, Ophthalmology, 2009 - 2012
- New York Downtown HospitalInternship, Internal Medicine, 2008 - 2009
- Emory University School of MedicineClass of 2008
Certifications & Licensure
- MA State Medical License 2012 - 2025
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 37 citationsFuchs endothelial cornea dystrophy: a review of the genetics behind disease development.Cecily E. Hamill, Thore Schmedt, Ula V. Jurkunas
Seminars in Ophthalmology. 2013-10-18 - 113 citationsActivation of Protease-Activated Receptor-1 Triggers Astrogliosis after Brain InjuryOlivier Nicole, Anna Goldshmidt, Cecily E. Hamill, Scott D. Sorensen, Aristide A. Sastre
The Journal of Neuroscience. 2005-04-27 - 58 citationsMenadione-Induced DNA Damage Leads to Mitochondrial Dysfunction and Fragmentation During Rosette Formation in Fuchs Endothelial Corneal DystrophyAdna Halilovic, Thore Schmedt, Anne-Sophie Benischke, Cecily E. Hamill, Yuming Chen
Antioxidants & Redox Signaling. 2016-06-21
Grant Support
- The Role Of PAR1 In Substantia Nigra PathophysiologyNational Institute Of Neurological Disorders And Stroke2005–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: